Highlight
This study shows that venting gastrostomy tube placement in patients with malignant bowel obstruction significantly improves objective quality of life measures, including diet advancement, reduction in vomiting episodes, and decreased antiemetic medication requirements. Placement success rates exceed 90%, although specific factors such as non-White race and presence of ascites increase the risk of unsuccessful placement.
Study Background
Malignant bowel obstruction (MBO) is a common complication in advanced cancer patients, particularly those with gastrointestinal and gynecologic malignancies. It often heralds a poor prognosis and causes distressing symptoms such as nausea, vomiting, abdominal pain, and inability to tolerate oral intake. Symptom management is crucial for comfort and quality of life in this palliative context. Venting gastrostomy tubes are indicated as a minimally invasive surgical intervention to relieve gastrointestinal distension by decompressing the obstructed bowel. Although widely used clinically, robust data on objective quality of life improvements and predictors of successful placement are limited.
Study Design
This retrospective cohort study analyzed patients who underwent or had attempted venting gastrostomy tube placement between 2015 and 2024. The cohort comprised 221 cancer patients with MBO at a single institution. The research compared patients’ dietary intake status, frequency of emesis episodes, and antiemetic medication use before and after gastrostomy tube placement. The primary outcomes focused on objective clinical parameters reflecting quality of life. The study also investigated demographic and clinical factors associated with unsuccessful placement.
Key Findings
Out of 3,701 gastrostomy tubes placed or attempted during the study period, 221 were venting gastrostomy tubes for malignant bowel obstruction. Successful venting gastrostomy tube placement was achieved in 203 patients (91.9%) utilizing endoscopic, open, or laparoscopic surgical approaches. Placement failure occurred in 18 patients (8.1%).
Statistical analysis revealed two significant predictors of unsuccessful placement: non-White race (relative risk 2.88, P = 0.026) and presence of ascites (relative risk 3.03, P = 0.030). These findings warrant further investigation into potential barriers including anatomic challenges and health disparities.
Importantly, among patients with successful tube placement, there were clinically and statistically significant improvements in objective quality of life metrics:
- Dietary status improved progressively from baseline before gastrostomy tube placement, immediately after placement, and at discharge (P < 0.001).
- Daily episodes of emesis decreased from a median of 0.5 prior to placement to 0 post-placement (P < 0.001).
- Antiemetic requirement decreased substantially from a median of 2 doses daily before to 0.5 doses post-placement (P < 0.001).
These findings confirm that venting gastrostomy tubes offer symptomatic relief and restore a measure of oral intake tolerance in the palliative setting.
Expert Commentary
This study contributes meaningful evidence supporting venting gastrostomy tube placement as an effective palliative intervention in patients with malignant bowel obstruction. The improvement in objective measures such as diet and emesis underscores its clinical utility beyond anecdotal experience.
The association of ascites with placement failure aligns with existing surgical knowledge, as ascites can complicate percutaneous access and increase infection risk. The finding that non-White race was associated with unsuccessful placement is intriguing and points to potential disparities or anatomical factors requiring further exploration.
Limitations include the retrospective design and single-center scope, which may affect generalizability. The moderate sample size limits the capacity for multivariable risk adjustment. Future prospective, multicenter studies are needed to validate these results and optimize patient selection criteria.
Conclusion
Venting gastrostomy tube placement in malignant bowel obstruction offers significant improvements in clinically relevant quality of life parameters, including better diet tolerance and reduced vomiting and medication use. The procedure is highly successful, though certain patient factors, notably ascites and racial background, may increase risk of failure.
These findings support the integration of venting gastrostomy tubes into palliative care algorithms for advanced cancer patients with bowel obstruction. Further research should aim to refine patient selection and address barriers to successful placement to maximize benefit.
